Tokyo, Japan

Kenji Nagahari

This inventor holds 5 USPTO granted patents. Top assignees: Research Association for Biotechnology, Acceleron Pharma Inc., Mitsubishi Chemical Industries Limited. Active years: 1989-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenji Nagahari. Retrieved from https://idiyas.com/inventor/kenji-nagahari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 40.0

Average Co-Inventor Count = 11.8

ph-index = 3

Forward Citations = 216(Granted Patents)


Company Filing History:


Years Active: 1989-2009

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Kenji Nagahari: Innovator in Biotechnology

Introduction

Kenji Nagahari is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the area of cDNA research. With a total of 5 patents to his name, Nagahari's work has advanced our understanding of polypeptides and their functions.

Latest Patents

One of Nagahari's latest patents is Heart20049410, which focuses on full-length cDNA and polypeptides. This patent provides novel full-length cDNAs derived from human sources. The full-length nucleotide sequences of the cDNA and the amino acid sequences encoded by these nucleotide sequences have been meticulously determined. The significance of this invention lies in the fact that the cDNA is full-length and contains the translation start site, offering valuable information for analyzing the functions of the polypeptide.

Career Highlights

Throughout his career, Kenji Nagahari has worked with notable organizations such as the Research Association for Biotechnology and Mitsubishi Chemical Industries Limited. His experience in these institutions has allowed him to develop innovative solutions and contribute to advancements in biotechnology.

Collaborations

Nagahari has collaborated with esteemed colleagues, including Takao Isogai and Tomoyasu Sugiyama. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field.

Conclusion

Kenji Nagahari's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the understanding of cDNA and polypeptides, paving the way for future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…